Prion protein aggregation

Current Science

Volumn 101, Issue 10, 2011, Pages 1311-1327

  Jain, Shweta ^a   Udgaonkar, Jayant B ^a  

^a TATA INSTITUTE OF FUNDAMENTAL RESEARCH   (India)

Author keywords

Alternative pathways; Amyloid fibrils; Oligomers; Prion protein; Structural heterogeneity

Indexed keywords

EID: 84860690734     PISSN: 00113891     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (206)

1. Chesebro, B. et al., Identification of scrapie prion proteinspecific mRNA in scrapie-infected and uninfected brain. Nature, 1985, 315, 331-333.
2. Oesch, B. et al., A cellular gene encodes scrapie PrP 27-30 protein. Cell, 1985, 40, 735-746.
3. Kretzschmar, H. A., Prusiner, S. B., Stowring, L. E. and DeArmond, S. J., Scrapie prion proteins are synthesized in neurons. Am. J. Pathol., 1986, 122, 1-5.
4. Stahl, N., Borchelt, D. R., Hsiao, K. and Prusiner, S. B., Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell, 1987, 51, 229-240.
5. Miura, T., Hori-i, A. and Takeuchi, H., Metal-dependent alphahelix formation promoted by the glycine-rich octapeptide region of prion protein. FEBS Lett., 1996, 396, 248-252.
6. Riek, R., Hornemann, S., Wider, G., Glockshuber, R. and Wuthrich, K., NMR characterization of the full-length recombinant murine prion protein, mPrP (23-231). FEBS Lett., 1997, 413, 282-288.
7. Stockel, J., Safar, J., Wallace, A. C., Cohen, F. E. and Prusiner, S. B., Prion protein selectively binds copper(II) ions. Biochemistry, 1998, 37, 7185-7193.
8. Chiesa, R. and Harris, D. A., Fishing for prion protein function. PLoS Biol., 2009, 7, e75.
9. Bremer, J. et al., Axonal prion protein is required for peripheral myelin maintenance. Nature Neurosci., 2010, 13, 310-318.
10. Prusiner, S. B., Novel proteinaceous infectious particles cause scrapie. Science, 1982, 216, 136-144.
11. Prusiner, S. B., Prions. Proc. Natl. Acad. Sci. USA, 1998, 95, 13363-13383.
12. Creutzfeldt, H. G., Uber eine eigenartige herdformige Erkrankung des Zentralnervensystems. Z. Gesamte Neurol. Psychiatr., 1920, 57, 1-18.
13. Jakob, A., Uber eigenartige Erkrankungen des Zentralnervensystems mit bemerkenswertem anatomischen Befunde (spatische Pseudoskelerose-Encephalomyelopathie mit disseminierten Degenerationsherden). Z. Gesamte Neurol. Psychiatr., 1921, 64, 147-228.
14. Kirschbaum, W. R., Jakob-Creutzfeldt Disease, Elsevier, Amsterdam, 1968.
15. Klatzo, I., Gajdusek, D. C. and Zigas, V., Pathology of Kuru. Lab. Invest., 1959, 8, 799-847.
16. Hadlow, W. J., Myopathies of livestock. Lab. Invest., 1959, 8, 1478-1498.
17. Gordon, W. S., Advances in veterinary research. Vet. Rec., 1946, 58, 516-525.
18. Sigurdsson, B., Rida, a chronic encephalitis of sheep with general remarks on infections which develop slowly and some of their special characteristics. Br. Vet. J., 1954, 110, 341-354.
19. Hadlow, W. J., Neuropathology and the scrapie-kuru connection. Brain Pathol., 1995, 5, 27-31.
20. Alper, T., Haig, D. A. and Clarke, M. C., The exceptionally small size of the scrapie agent. Biochem. Biophys. Res. Commun., 1966, 22, 278-284.
21. Alper, T., Cramp, W. A., Haig, D. A. and Clarke, M. C., Does the agent of scrapie replicate without nucleic acid? Nature, 1967, 214, 764-766.
22. Latarjet, R., Muel, B., Haig, D. A., Clarke, M. C. and Alper, T., Inactivation of the scrapie agent by near monochromatic ultraviolet light. Nature, 1970, 227, 1341-1343.
23. Gibbs Jr, C. J., Gajdusek, D. C. and Latarjet, R., Unusual resistance to ionizing radiation of the viruses of Kuru, Creutzfeldt- Jakob disease and scrapie. Proc. Natl. Acad. Sci. USA, 1978, 75, 6268-6270.
24. Pattison, I. H., In Slow, Latent and Temperate Virus Infections, NINDB Monograph 2 (eds Gajdusek, D. C., Gibbs Jr, C. J. and Alpers, M. P.), US Government Printing Office, Washington, DC, 1965, pp. 249-257.
25. Gibbons, R. A. and Hunter, G. D., Nature of the scrapie agent. Nature, 1967, 215, 1041-1043.
26. Griffith, J. S., Self-replication and scrapie. Nature, 1967, 215, 1043-1044.
27. Pattison, I. H. and Jones, K. M., The possible nature of the transmissible agent of scrapie. Vet. Rec., 1967, 80, 2-9.
28. Hunter, G. D., Kimberlin, R. H. and Gibbons, R. A., Scrapie: a modified membrane hypothesis. J. Theor. Biol., 1968, 20, 355-357.
29. Field, E. J., Farmer, F., Caspary, E. A. and Joyce, G., Susceptibility of scrapie agent to ionizing radiation. Nature, 1969, 222, 90-91.
30. Hunter, G. D., Scrapie: a prototype slow infection. J. Infect. Dis., 1972, 125, 427-440.
31. Hunter, G. D. and Millson, G. C., Attempts to release the scrapie agent from tissue debris. J. Comp. Pathol., 1967, 77, 301-307.
32. Prusiner, S. B., Groth, D. F., Cochran, S. P., Masiarz, F. R., McKinley, M. P. and Martinez, H. M., Molecular properties, partial purification, and assay by incubation period measurements of the hamster scrapie agent. Biochemistry, 1980, 19, 4883-4891.
33. Prusiner, S. B., Groth, D. F., McKinley, M. P., Cochran, S. P., Bowman, K. A. and Kasper, K. C., Thiocyanate and hydroxyl ions inactivate the scrapie agent. Proc. Natl. Acad. Sci. USA, 1981, 78, 4606-4610.
34. Bolton, D. C., McKinley, M. P. and Prusiner, S. B., Identification of a protein that purifies with the scrapie prion. Science, 1982, 218, 1309-1311.
35. Prusiner, S. B., Groth, D. F., Bolton, D. C., Kent, S. B. and Hood, L. E., Purification and structural studies of a major scrapie prion protein. Cell, 1984, 38, 127-134.
36. Basler, K. et al., Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene. Cell, 1986, 46, 417-428.
37. Locht, C., Chesebro, B., Race, R. and Keith, J. M., Molecular cloning and complete sequence of prion protein cDNA from mouse brain infected with the scrapie agent. Proc. Natl. Acad. Sci. USA, 1986, 83, 6372-6376.
38. Meyer, R. K., McKinley, M. P., Bowman, K. A., Braunfeld, M. B., Barry, R. A. and Prusiner, S. B., Separation and properties of cellular and scrapie prion proteins. Proc. Natl. Acad. Sci. USA, 1986, 83, 2310-2314.
39. Bueler, H. et al., Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature, 1992, 356, 577-582.
40. Bueler, H., Aguzzi, A., Sailer, A., Greiner, R. A., Autenried, P., Aguet, M. and Weissmann, C., Mice devoid of PrP are resistant to scrapie. Cell, 1993, 73, 1339-1347.
41. Westaway, D. et al., Degeneration of skeletal muscle, peripheral nerves, and the central nervous system in transgenic mice overexpressing wild-type prion proteins. Cell, 1994, 76, 117-129.
42. Wang, F., Wang, X., Yuan, C. G. and Ma, J., Generating a prion with bacterially expressed recombinant prion protein. Science, 2010, 327, 1132-1135.
43. Kim, J. I. et al., Mammalian prions generated from bacterially expressed prion protein in the absence of any mammalian cofactors. J. Biol. Chem., 2010, 285, 14083-14087.
44. Eanes, E. D. and Glenner, G. G., X-ray diffraction studies on amyloid filaments. J. Histochem. Cytochem., 1968, 16, 673-677.
45. Sunde, M., Serpell, L. C., Bartlam, M., Fraser, P. E., Pepys, M. B. and Blake, C. C., Common core structure of amyloid fibrils by synchrotron X-ray diffraction. J. Mol. Biol., 1997, 273, 729-739.
46. Selkoe, D. J., Folding proteins in fatal ways. Nature, 2003, 426, 900-904.
47. Chiti, F. and Dobson, C. M., Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem., 2006, 75, 333-366.
48. Pan, K. M. et al., Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc. Natl. Acad. Sci. USA, 1993, 90, 10962-10966.
49. Peretz, D., Scott, M. R., Groth, D., Williamson, R. A., Burton, D. R., Cohen, F. E. and Prusiner, S. B., Strain-specified relative conformational stability of the scrapie prion protein. Protein Sci., 2001, 10, 854-863.
50. Prusiner, S. B., Bolton, D. C., Groth, D. F., Bowman, K. A., Cochran, S. P. and McKinley, M. P., Further purification and characterization of scrapie prions. Biochemistry, 1982, 21, 6942-6950.
51. Prusiner, S. B., McKinley, M. P., Bowman, K. A., Bolton, D. C., Bendheim, P. E., Groth, D. F. and Glenner, G. G., Scrapie prions aggregate to form amyloid-like birefringent rods. Cell, 1983, 35, 349-358.
52. DeArmond, S. J., McKinley, M. P., Barry, R. A., Braunfeld, M. B., McColloch, J. R. and Prusiner, S. B., Identification of prion amyloid filaments in scrapie-infected brain. Cell, 1985, 41, 221-235.
53. Kitamoto, T., Tateishi, J., Tashima, T., Takeshita, I., Barry, R. A., DeArmond, S. J. and Prusiner, S. B., Amyloid plaques in Creutzfeldt-Jakob disease stain with prion protein antibodies. Ann. Neurol., 1986, 20, 204-208.
54. Roberts, G. W., Lofthouse, R., Brown, R., Crow, T. J., Barry, R. A. and Prusiner, S. B., Prion-protein immunoreactivity in human transmissible dementias. N. Engl. J. Med., 1986, 315, 1231-1233.
55. Brandner, S., Raeber, A., Sailer, A., Blattler, T., Fischer, M., Weissmann, C. and Aguzzi, A., Normal host prion protein (PrPC) is required for scrapie spread within the central nervous system. Proc. Natl. Acad. Sci. USA, 1996, 93, 13148-13151.
56. Mallucci, G., Dickinson, A., Linehan, J., Klohn, P. C., Brandner, S. and Collinge, J., Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science, 2003, 302, 871-874.
57. Mallucci, G. R. et al., Targeting cellular prion protein reverses early cognitive deficits and neurophysiological dysfunction in prion-infected mice. Neuron, 2007, 53, 325-335.
58. Tateishi, J. and Kitamoto, T., Inherited prion diseases and transmission to rodents. Brain Pathol., 1995, 5, 53-59.
59. Tateishi, J., Kitamoto, T., Hoque, M. Z. and Furukawa, H., Experimental transmission of Creutzfeldt-Jakob disease and related diseases to rodents. Neurology, 1996, 46, 532-537.
60. Lasmezas, C. I. et al., Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein. Science, 1997, 275, 402-405.
61. Chiesa, R. et al., Molecular distinction between pathogenic and infectious properties of the prion protein. J. Virol., 2003, 77, 7611-7622.
62. Gambetti, P. et al., A novel human disease with abnormal prion protein sensitive to protease. Ann. Neurol., 2008, 63, 697-708.
63. Head, M. W., Knight, R., Zeidler, M., Yull, H., Barlow, A. and Ironside, J. W., A case of protease sensitive prionopathy in a patient in the UK. Neuropathol. Appl. Neurobiol., 2009, 35, 628-632.
64. Caughey, B. and Lansbury, P. T., Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu. Rev. Neurosci., 2003, 26, 267-298.
65. Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W. and Glabe, C. G., Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science, 2003, 300, 486-489.
66. Kayed, R., Sokolov, Y., Edmonds, B., McIntire, T. M., Milton, S. C., Hall, J. E. and Glabe, C. G., Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases. J. Biol. Chem., 2004, 279, 46363-46366.
67. Silveira, J. R., Raymond, G. J., Hughson, A. G., Race, R. E., Sim, V. L., Hayes, S. F. and Caughey, B., The most infectious prion protein particles. Nature, 2005, 437, 257-261.
68. Novitskaya, V., Bocharova, O. V., Bronstein, I. and Baskakov, I. V., Amyloid fibrils of mammalian prion protein are highly toxic to cultured cells and primary neurons. J. Biol. Chem., 2006, 281, 13828-13836.
69. Xue, W. F., Hellewell, A. L., Gosal, W. S., Homans, S. W., Hewitt, E. W. and Radford, S. E., Fibril fragmentation enhances amyloid cytotoxicity. J. Biol. Chem., 2009, 284, 34272-34282.
70. Riek, R., Hornemann, S., Wider, G., Billeter, M., Glockshuber, R. and Wuthrich, K., NMR structure of the mouse prion protein domain PrP(121-321). Nature, 1996, 382, 180-182.
71. Stahl, N., Baldwin, M. A., Teplow, D. B., Hood, L., Gibson, B. W., Burlingame, A. L. and Prusiner, S. B., Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing. Biochemistry, 1993, 32, 1991-2002.
72. Baldwin, M. A., Mass spectrometric analysis of prion proteins. Adv. Protein Chem., 2001, 57, 29-54.
73. Peretz, D. et al., A conformational transition at the N terminus of the prion protein features in formation of the scrapie isoform. J. Mol. Biol., 1997, 273, 614-622.
74. Wille, H. et al., Structural studies of the scrapie prion protein by electron crystallography. Proc. Natl. Acad. Sci. USA, 2002, 99, 3563-3568.
75. Govaerts, C., Wille, H., Prusiner, S. B. and Cohen, F. E., Evidence for assembly of prions with left-handed beta-helices into trimers. Proc. Natl. Acad. Sci. USA, 2004, 101, 8342-8347.
76. DeMarco, M. L. and Daggett, V., From conversion to aggregation: protofibril formation of the prion protein. Proc. Natl. Acad. Sci. USA, 2004, 101, 2293-2298.
77. DeMarco, M. L., Silveira, J., Caughey, B. and Daggett, V., Structural properties of prion protein protofibrils and fibrils: an experimental assessment of atomic models. Biochemistry, 2006, 45, 15573-15582.
78. Dima, R. I. and Thirumalai, D., Exploring the propensities of helices in PrP(C) to form beta sheet using NMR structures and sequence alignments. Biophys. J., 2002, 83, 1268-1280.
79. Dima, R. I. and Thirumalai, D., Probing the instabilities in the dynamics of helical fragments from mouse PrPC. Proc. Natl. Acad. Sci. USA, 2004, 101, 15335-15340.
80. Legname, G., Baskakov, I. V., Nguyen, H. O., Riesner, D., Cohen, F. E., DeArmond, S. J. and Prusiner, S. B., Synthetic mammalian prions. Science, 2004, 305, 673-676.
81. Lu, X., Wintrode, P. L. and Surewicz, W. K., Beta-sheet core of human prion protein amyloid fibrils as determined by hydrogen/ deuterium exchange. Proc. Natl. Acad. Sci. USA, 2007, 104, 1510-1515.
82. Cobb, N. J., Sonnichsen, F. D., McHaourab, H. and Surewicz, W. K., Molecular architecture of human prion protein amyloid: a parallel, in-register beta-structure. Proc. Natl. Acad. Sci. USA, 2007, 104, 18946-18951.
83. Tycko, R., Savtchenko, R., Ostapchenko, V. G., Makarava, N. and Baskakov, I. V., The alpha-helical C-terminal domain of fulllength recombinant PrP converts to an in-register parallel betasheet structure in PrP fibrils: evidence from solid state nuclear magnetic resonance. Biochemistry, 2010, 49, 9488-9497.
84. Antzutkin, O. N., Balbach, J. J., Leapman, R. D., Rizzo, N. W., Reed, J. and Tycko, R., Multiple quantum solid-state NMR indicates a parallel, not antiparallel, organization of beta-sheets in Alzheimer's beta-amyloid fibrils. Proc. Natl. Acad. Sci. USA, 2000, 97, 13045-13050.
85. Petkova, A. T., Ishii, Y., Balbach, J. J., Antzutkin, O. N., Leapman, R. D., Delaglio, F. and Tycko, R., A structural model for Alzheimer's beta-amyloid fibrils based on experimental constraints from solid state NMR. Proc. Natl. Acad. Sci. USA, 2002, 99, 16742-16747.
86. Der-Sarkissian, A., Jao, C. C., Chen, J. and Langen, R., Structural organization of alpha-synuclein fibrils studied by sitedirected spin labelling. J. Biol. Chem., 2003, 278, 37530-37535.
87. Margittai, M. and Langen, R., Template-assisted filament growth by parallel stacking of tau. Proc. Natl. Acad. Sci. USA, 2004, 101, 10278-10283.
88. Jha, A., Udgaonkar, J. B. and Krishnamoorthy, G., Characterization of the heterogeneity and specificity of interpolypeptide interactions in amyloid protofibrils by measurement of sitespecific fluorescence anisotropy decay kinetics. J. Mol. Biol., 2009, 393, 735-752.
89. Shewmaker, F., Wickner, R. B. and Tycko, R., Amyloid of the prion domain of Sup35p has an in-register parallel beta-sheet structure. Proc. Natl. Acad. Sci. USA, 2006, 103, 19754-19759.
90. Baxa, U., Wickner, R. B., Steven, A. C., Anderson, D. E., Marekov, L. N., Yau, W. M. and Tycko, R., Characterization of betasheet structure in Ure2p1-89 yeast prion fibrils by solid-state nuclear magnetic resonance. Biochemistry, 2007, 46, 13149-13162.
91. Wickner, R. B., Dyda, F. and Tycko, R., Amyloid of Rnq1p, the basis of the [PIN+] prion, has a parallel in-register beta-sheet structure. Proc. Natl. Acad. Sci. USA, 2008, 105, 2403-2408.
92. Helmus, J. J., Surewicz, K., Nadaud, P. S., Surewicz, W. K. and Jaroniec, C. P., Molecular conformation and dynamics of the Y145Stop variant of human prion protein in amyloid fibrils. Proc. Natl. Acad. Sci. USA, 2008, 105, 6284-6289.
93. Lim, K. H. et al., Solid-state NMR structural studies of the fibril form of a mutant mouse prion peptide PrP89-143(P101L). Solid State Nucl. Magn. Reson., 2006, 29, 183-190.
94. Damo, S. M., Phillips, A. H., Young, A. L., Li, S., Woods Jr, V. L. and Wemmer, D. E., Probing the conformation of a prion protein fibril with hydrogen exchange. J. Biol. Chem., 2010, 285, 32303-32311.
95. Shewmaker, F., Kryndushkin, D., Chen, B., Tycko, R. and Wickner, R. B., Two prion variants of Sup35p have in-register parallel beta-sheet structures, independent of hydration. Biochemistry, 2009, 48, 5074-5082.
96. Legname, G., Nguyen, H. O., Baskakov, I. V., Cohen, F. E., Dearmond, S. J. and Prusiner, S. B., Strain-specified characteristics of mouse synthetic prions. Proc. Natl. Acad. Sci. USA, 2005, 102, 2168-2173.
97. Smirnovas, V., Baron, G. S., Offerdahl, D. K., Raymond, G. J., Caughey, B. and Surewicz, W. K., Structural organization of brain-derived mammalian prions examined by hydrogen- deuterium exchange. Nature Struct. Mol. Biol., 2011, 18, 504-506.
98. Booth, D. R. et al., Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis. Nature, 1997, 385, 787-793.
99. Kelly, J. W., The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways. Curr. Opin. Struct. Biol., 1998, 8, 101-106.
100. Uversky, V. N. and Fink, A. L., Conformational constraints for amyloid fibrillation: the importance of being unfolded. Biochim. Biophys. Acta, 2004, 1698, 131-153.
101. Liu, K., Cho, H. S., Lashuel, H. A., Kelly, J. W. and Wemmer, D. E., A glimpse of a possible amyloidogenic intermediate of transthyretin. Nature Struct. Biol., 2000, 7, 754-757.
102. McParland, V. J., Kalverda, A. P., Homans, S. W. and Radford, S. E., Structural properties of an amyloid precursor of beta(2)-microglobulin. Nature Struct. Biol., 2002, 9, 326-331.
103. Gianni, S., Ivarsson, Y., De Simone, A., Travaglini-Allocatelli, C., Brunori, M. and Vendruscolo, M., Structural characterization of a misfolded intermediate populated during the folding process of a PDZ domain. Nature Struct. Mol. Biol., 2010, 17, 1431-1437.
104. Chiti, F. and Dobson, C. M., Amyloid formation by globular proteins under native conditions. Nature Chem. Biol., 2009, 5, 15-22.
105. Bishop, M. F. and Ferrone, F. A., Kinetics of nucleationcontrolled polymerization. A perturbation treatment for use with a secondary pathway. Biophys. J., 1984, 46, 631-644.
106. Oosawa, F. and Kasai, M., A theory of linear and helical aggregations of macromolecules. J. Mol. Biol., 1962, 4, 10-21.
107. Harper, J. D. and Lansbury Jr, P. T., Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu. Rev. Biochem., 1997, 66, 385-407.
108. Ferrone, F., Analysis of protein aggregation kinetics. Methods Enzymol., 1999, 309, 256-274.
109. Kumar, S. and Udgaonkar, J. B., Mechanisms of amyloid fibril formation by proteins. Curr. Sci., 2010, 98, 639-656.
110. Romberg, L., Simon, M. and Erickson, H. P., Polymerization of Ftsz, a bacterial homolog of tubulin, assembly cooperative? J. Biol. Chem., 2001, 276, 11743-11753.
111. Frieden, C., Protein aggregation processes: in search of the mechanism. Protein Sci., 2007, 16, 2334-2344.
112. Serio, T. R. et al., Nucleated conformational conversion and the replication of conformational information by a prion determinant. Science, 2000, 289, 1317-1321.
113. Collins, S. R., Douglass, A., Vale, R. D. and Weissman, J. S., Mechanism of prion propagation: amyloid growth occurs by monomer addition. PLoS Biol., 2004, 2, e321.
114. Baskakov, I. V. and Bocharova, O. V., In vitro conversion of mammalian prion protein into amyloid fibrils displays unusual features. Biochemistry, 2005, 44, 2339-2348.
115. Bhattacharyya, A. M., Thakur, A. K. and Wetzel, R., Polyglutamine aggregation nucleation: thermodynamics of a highly unfavourable protein folding reaction. Proc. Natl. Acad. Sci. USA, 2005, 102, 15400-15405.
116. Xue, W. F., Homans, S. W. and Radford, S. E., Systematic analysis of nucleation-dependent polymerization reveals new insights into the mechanism of amyloid self-assembly. Proc. Natl. Acad. Sci. USA, 2008, 105, 8926-8931.
117. Chen, S., Ferrone, F. A. and Wetzel, R., Huntington's disease age-of-onset linked to polyglutamine aggregation nucleation. Proc. Natl. Acad. Sci. USA, 2002, 99, 11884-11889.
118. Ferrone, F. A., Hofrichter, J., Sunshine, H. R. and Eaton, W. A., Kinetic studies on photolysis-induced gelation of sickle cell hemoglobin suggest a new mechanism. Biophys. J., 1980, 32, 361-380.
119. Wegner, A., Spontaneous fragmentation of actin filaments in physiological conditions. Nature, 1982, 296, 266-267.
120. Wegner, A. and Savko, P., Fragmentation of actin filaments. Biochemistry, 1982, 21, 1909-1913.
121. Modler, A. J., Gast, K., Lutsch, G. and Damaschun, G., Assembly of amyloid protofibrils via critical oligomers - a novel pathway of amyloid formation. J. Mol. Biol., 2003, 325, 135-148.
122. Kumar, S. and Udgaonkar, J. B., Structurally distinct amyloid protofibrils form on separate pathways of aggregation of a small protein. Biochemistry, 2009, 48, 6441-6449.
123. Kumar, S. and Udgaonkar, J. B., Conformational conversion may precede or follow aggregate elongation on alternative pathways of amyloid protofibril formation. J. Mol. Biol., 2009, 385, 1266-1276.
124. Walsh, D. M., Lomakin, A., Benedek, G. B., Condron, M. M. and Teplow, D. B., Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate. J. Biol. Chem., 1997, 272, 22364-22372.
125. Walsh, D. M. et al., Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates. J. Biol. Chem., 1999, 274, 25945-25952.
126. Kheterpal, I., Chen, M., Cook, K. D. and Wetzel, R., Structural differences in Aβ amyloid protofibrils and fibrils mapped by hydrogen exchange-mass spectrometry with on-line proteolytic fragmentation. J. Mol. Biol., 2006, 361, 785-795.
127. Chimon, S., Shaibat, M. A., Jones, C. R., Calero, D. C., Aizezi, B. and Ishii, Y., Evidence of fibril-like beta-sheet structures in a neurotoxic amyloid intermediate of Alzheimer's beta-amyloid. Nature Struct. Mol. Biol., 2007, 14, 1157-1164.
128. Jain, S. and Udgaonkar, J. B., Evidence for stepwise formation of amyloid fibrils by the mouse prion protein. J. Mol. Biol., 2008, 382, 1228-1241.
129. Jain, S. and Udgaonkar, J. B., Defining the pathway of worm-like amyloid fibril formation by the mouse prion protein by delineation of the productive and unproductive oligomerization reactions. Biochemistry, 2011, 50, 1153-1161.
130. Esler, W. P. et al., Alzheimer's disease amyloid propagation by a template-dependent dock-lock mechanism. Biochemistry, 2000, 39, 6288-6295.
131. Scheibel, T., Bloom, J. and Lindquist, S. L., The elongation of yeast prion fibers involves separable steps of association and conversion. Proc. Natl. Acad. Sci. USA, 2004, 101, 2287-2292.
132. Kumar, S., Mohanty, S. K. and Udgaonkar, J. B., Mechanism of formation of amyloid protofibrils of barstar from soluble oligomers: evidence for multiple steps and lateral association coupled to conformational conversion. J. Mol. Biol., 2007, 367, 1186-1204.
133. Jain, S. and Udgaonkar, J. B., Salt-induced modulation of the pathway of amyloid fibril formation by the mouse prion protein. Biochemistry, 2010, 49, 7615-7624.
134. Toyama, B. H. and Weissman, J. S., Amyloid structure: conformational diversity and consequences. Annu. Rev. Biochem., 2011, 80, 557-585.
135. Prusiner, S. B., Molecular biology of prion diseases. Science, 1991, 252, 1515-1522.
136. Jarrett, J. T. and Lansbury Jr, P. T., Seeding 'one-dimensional crystallization' of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell, 1993, 73, 1055-1058.
137. Weissmann, C., The state of the prion. Nature Rev. Microbiol., 2004, 2, 861-871.
138. Pattison, I. H. and Millson, G. C., Scrapie produced experimentally in goats with special reference to the clinical syndrome. J. Comp. Pathol., 1961, 71, 101-108.
139. Fraser, H. and Dickinson, A. G., The sequential development of the brain lesion of scrapie in three strains of mice. J. Comp. Pathol., 1968, 78, 301-311.
140. Fraser, H. and Dickinson, A. G., Scrapie in mice. Agent-strain differences in the distribution and intensity of grey matter vacuolation. J. Comp. Pathol., 1973, 83, 29-40.
141. Hecker, R. et al., Replication of distinct scrapie prion isolates is region specific in brains of transgenic mice and hamsters. Genes Dev., 1992, 6, 1213-1228.
142. DeArmond, S. J., Yang, S. L., Lee, A., Bowler, R., Taraboulos, A., Groth, D. and Prusiner, S. B., Three scrapie prion isolates exhibit different accumulation patterns of the prion protein scrapie isoform. Proc. Natl. Acad. Sci. USA, 1993, 90, 6449-6453.
143. Collinge, J., Prion diseases of humans and animals: their causes and molecular basis. Annu. Rev. Neurosci., 2001, 24, 519-550.
144. Bessen, R. A. and Marsh, R. F., Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J. Virol., 1994, 68, 7859-7868.
145. Caughey, B., Raymond, G. J. and Bessen, R. A., Straindependent differences in beta-sheet conformations of abnormal prion protein. J. Biol. Chem., 1998, 273, 32230-32235.
146. Safar, J. et al., Eight prion strains have PrP(Sc) molecules with different conformations. Nature Med., 1998, 4, 1157-1165.
147. Somerville, R. A., TSE agent strains and PrP: reconciling structure and function. Trends Biochem. Sci., 2002, 27, 606-612.
148. Bruce, M. E. and Fraser, H., Scrapie strain variation and its implications. Curr. Top. Microbiol. Immunol., 1991, 172, 125-138.
149. Priola, S. A. and Lawson, V. A., Glycosylation influences crossspecies formation of protease-resistant prion protein. EMBO J., 2001, 20, 6692-6699.
150. Vorberg, I. and Priola, S. A., Molecular basis of scrapie strain glycoform variation. J. Biol. Chem., 2002, 277, 36775-36781.
151. Chien, P., Weissman, J. S. and DePace, A. H., Emerging principles of conformation-based prion inheritance. Annu. Rev. Biochem., 2004, 73, 617-656.
152. Hornemann, S., Schorn, C. and Wuthrich, K., NMR structure of the bovine prion protein isolated from healthy calf brains. EMBO Rep., 2004, 5, 1159-1164.
153. Wildegger, G., Liemann, S. and Glockshuber, R., Extremely rapid folding of the C-terminal domain of the prion protein without kinetic intermediates. Nature Struct. Biol., 1999, 6, 550-553.
154. Apetri, A. C. and Surewicz, W. K., Kinetic intermediate in the folding of human prion protein. J. Biol. Chem., 2002, 277, 44589-44592.
155. Apetri, A. C., Maki, K., Roder, H. and Surewicz, W. K., Early intermediate in human prion protein folding as evidenced by ultrarapid mixing experiments. J. Am. Chem. Soc., 2006, 128, 11673-11678.
156. Nicholson, E. M., Mo, H., Prusiner, S. B., Cohen, F. E. and Marqusee, S., Differences between the prion protein and its homolog Doppel: a partially structured state with implications for scrapie formation. J. Mol. Biol., 2002, 316, 807-815.
157. Kuwata, K., Li, H., Yamada, H., Legname, G., Prusiner, S. B., Akasaka, K. and James, T. L., Locally disordered conformer of the hamster prion protein: a crucial intermediate to PrPSc? Biochemistry, 2002, 41, 12277-12283.
158. Kocisko, D. A., Come, J. H., Priola, S. A., Chesebro, B., Raymond, G. J., Lansbury, P. T. and Caughey, B., Cell-free formation of protease-resistant prion protein. Nature, 1994, 370, 471-474.
159. Cohen, F. E., Pan, K. M., Huang, Z., Baldwin, M., Fletterick, R. J. and Prusiner, S. B., Structural clues to prion replication. Science, 1994, 264, 530-531.
160. Swietnicki, W., Petersen, R. B., Gambetti, P. and Surewicz, W. K., Familial mutations and the thermodynamic stability of the recombinant human prion protein. J. Biol. Chem., 1998, 273, 31048-31052.
161. Apetri, A. C., Surewicz, K. and Surewicz, W. K., The effect of disease-associated mutations on the folding pathway of human prion protein. J. Biol. Chem., 2004, 279, 18008-18014.
162. Morillas, M., Vanik, D. L. and Surewicz, W. K., On the mechanism of alpha-helix to beta-sheet transition in the recombinant prion protein. Biochemistry, 2001, 40, 6982-6987.
163. Caughey, B., Raymond, G. J., Ernst, D. and Race, R. E., N-terminal truncation of the scrapie-associated form of PrP by lysosomal protease(s): implications regarding the site of conversion of PrP to the protease-resistant state. J. Virol., 1991, 65, 6597-6603.
164. Borchelt, D. R., Taraboulos, A. and Prusiner, S. B., Evidence for synthesis of scrapie prion proteins in the endocytic pathway. J. Biol. Chem., 1992, 267, 16188-16199.
165. Swietnicki, W., Petersen, R., Gambetti, P. and Surewicz, W. K., pH-dependent stability and conformation of the recombinant human prion protein PrP (90-231). J. Biol. Chem., 1997, 272, 27517-27520.
166. Swietnicki, W., Morillas, M., Chen, S. G., Gambetti, P. and Surewicz, W. K., Aggregation and fibrillization of the recombinant human prion protein huPrP90-231. Biochemistry, 2000, 39, 424-431.
167. Baskakov, I. V., Legname, G., Prusiner, S. B. and Cohen, F. E., Folding of prion protein to its native alpha-helical conformation is under kinetic control. J. Biol. Chem., 2001, 276, 19687-19690.
168. Baskakov, I. V., Legname, G., Baldwin, M. A., Prusiner, S. B. and Cohen, F. E., Pathway complexity of prion protein assembly into amyloid. J. Biol. Chem., 2002, 277, 21140-21148.
169. Baskakov, I. V., Autocatalytic conversion of recombinant prion proteins displays a species barrier. J. Biol. Chem., 2004, 279, 7671-7677.
170. Bocharova, O. V., Breydo, L., Parfenov, A. S., Salnikov, V. V. and Baskakov, I. V., In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrP(Sc). J. Mol. Biol., 2005, 346, 645-659.
171. Jackson, G. S. et al., Reversible conversion of monomeric human prion protein between native and fibrilogenic conformations. Science, 1999, 283, 1935-1937.
172. Maiti, N. R. and Surewicz, W. K., The role of disulfide bridge in the folding and stability of the recombinant human prion protein. J. Biol. Chem., 2001, 276, 2427-2431.
173. Rezaei, H., Eghiaian, F., Perez, J., Doublet, B., Choiset, Y., Haertle, T. and Grosclaude, J., Sequential generation of two structurally distinct ovine prion protein soluble oligomers displaying different biochemical reactivities. J. Mol. Biol., 2005, 347, 665-679.
174. Vendrely, C. et al., Assembly of the full-length recombinant mouse prion protein I. Formation of soluble oligomers. Biochim. Biophys. Acta, 2005, 1724, 355-366.
175. Eghiaian, F. et al., Diversity in prion protein oligomerization pathways results from domain expansion as revealed by hydrogen/ deuterium exchange and disulfide linkage. Proc. Natl. Acad. Sci. USA, 2007, 104, 7414-7419.
176. Anderson, M., Bocharova, O. V., Makarava, N., Breydo, L., Salnikov, V. V. and Baskakov, I. V., Polymorphism and ultrastructural organization of prion protein amyloid fibrils: an insight from high resolution atomic force microscopy. J. Mol. Biol., 2006, 358, 580-596.
177. Colby, D. W., Giles, K., Legname, G., Wille, H., Baskakov, I. V., DeArmond, S. J. and Prusiner, S. B., Design and construction of diverse mammalian prion strains. Proc. Natl. Acad. Sci. USA, 2009, 106, 20417-20422.
178. Makarava, N. and Baskakov, I. V., The same primary structure of the prion protein yields two distinct self-propagating states. J. Biol. Chem., 2008, 283, 15988-15996.
179. Ostapchenko, V. G., Makarava, N., Savtchenko, R. and Baskakov, I. V., The polybasic N-terminal region of the prion protein controls the physical properties of both the cellular and fibrillar forms of PrP. J. Mol. Biol., 2008, 383, 1210-1224.
180. Ostapchenko, V. G., Sawaya, M. R., Makarava, N., Savtchenko, R., Nilsson, K. P., Eisenberg, D. and Baskakov, I. V., Two amyloid states of the prion protein display significantly different folding patterns. J. Mol. Biol., 2010, 400, 908-921.
181. Gosal, W. S., Morten, I. J., Hewitt, E. W., Smith, D. A., Thomson, N. H. and Radford, S. E., Competing pathways determine fibril morphology in the self-assembly of beta2-microglobulin into amyloid. J. Mol. Biol., 2005, 351, 850-864.
182. Apetri, A. C., Vanik, D. L. and Surewicz, W. K., Polymorphism at residue 129 modulates the conformational conversion of the D178N variant of human prion protein 90-231. Biochemistry, 2005, 44, 15880-15888.
183. Cobb, N. J., Apetri, A. C. and Surewicz, W. K., Prion protein amyloid formation under native like conditions involves refolding of the C-terminal α-helical domain. J. Biol. Chem., 2008, 283, 34704-34711.
184. Prusiner, S. B., Prion Biology and Diseases, Cold Spring Harbor, Monograph Series, 2004.
185. Wickner, R. B., Edskes, H. K., Shewmaker, F. and Nakayashiki, T., Prions of fungi: inherited structures and biological roles. Nature Rev. Microbiol., 2007, 5, 611-618.
186. Wickner, R. B. et al., Prion amyloid structure explains templating: how proteins can be genes. FEMS Yeast Res., 2010, 10, 980-991.
187. Wiltzius, J. J. W. et al., Molecular mechanisms for proteinencoded inheritance. Nature Struct. Mol. Biol., 2009, 16, 973-979.
188. Li, J., Browning, S., Mahal, S. P., Oelschlegel, A. M. and Weissmann, C., Darwinian evolution of prions in cell culture. Science, 2010, 327, 869-872.
189. Vanik, D. L., Surewicz, K. A. and Surewicz, W. K., Molecular basis of barriers for interspecies transmissibility of mammalian prions. Mol. Cell, 2004, 14, 139-145.
190. Jones, E. M. and Surewicz, W. K., Fibril conformation as the basis of species- and strain-dependent seeding specificity of mammalian prion amyloids. Cell, 2005, 121, 63-72.
191. Kundu, B., Maiti, N. R., Jones, E. M., Surewicz, K. A., Vanik, D. L. and Surewicz, W. K., Nucleation-dependent conformational conversion of the Y145Stop variant of human prion protein: structural clues for prion propagation. Proc. Natl. Acad. Sci. USA, 2003, 100, 12069-12074.
192. Apostol, M. I., Wiltzius, J. J. W., Sawaya, M. R., Cascio, D. and Eisenberg, D., Atomic structures suggest determinants of transmission barriers in mammalian prion disease. Biochemistry, 2011, 50, 2456-2463.
193. Aoyagi, H., Hasegawa, M. and Tamaoka, A., Fibrillogenic nuclei composed of P301L mutant tau induce elongation of P301L tau but not wild-type tau. J. Biol. Chem., 2007, 282, 20309-20318.
194. Frost, B., Ollesch, J., Wille, H. and Diamond, M. I., Conformational diversity of wild-type Tau fibrils specified by templated conformation change. J. Biol. Chem., 2009, 284, 3546-3551.
195. Frost, B. and Diamond, M. I., The expanding realm of prion phenomena in neurodegenerative disease. Prion, 2009, 3, 74-77.
196. Kane, M. D. et al., Evidence for seeding of beta-amyloid by intracerebral infusion of Alzheimer brain extracts in beta-amyloid precursor protein-transgenic mice. J. Neurosci., 2000, 20, 3606-3611.
197. Goedert, M., Spillantini, M. G., Serpell, L. C., Berriman, J., Smith, M. J., Jakes, R. and Crowther, R. A., From genetics to pathology: tau and alpha-synuclein assemblies in neurodegenerative diseases. Philos. Trans. R. Soc. London B Biol. Sci., 2001, 356, 213-227.
198. Walker, L. C., Callahan, M. J., Bian, F., Durham, R. A., Roher, A. E. and Lipinski, W. J., Exogenous induction of cerebral betaamyloidosis in betaAPP-transgenic mice. Peptides, 2002, 23, 1241-1247.
199. Yang, W., Dunlap, J. R., Andrews, R. B. and Wetzel, R., Aggregated polyglutamine peptides delivered to nuclei are toxic to mammalian cells. Hum. Mol. Genet., 2002, 11, 2905-2917.
200. Braak, H., Del Tredici, K., Rub, U., de Vos, R. A., Jansen Steur, E. N. and Braak, E., Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging, 2003, 24, 197-211.
201. Brouwers, N., Sleegers, K. and Van Broeckhoven, C., Molecular genetics of Alzheimer's disease: an update. Annu. Med., 2008, 40, 562-583.
202. Li, J. Y. et al., Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nature Med., 2008, 14, 501-503.
203. Clavaguera, F. et al., Transmission and spreading of tauopathy in transgenic mouse brain. Nature Cell Biol., 2009, 11, 909-913.
204. Desplats, P. et al., Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc. Natl. Acad. Sci. USA, 2009, 106, 13010-13015.
205. Frost, B., Jacks, R. L. and Diamond, M. I., Propagation of tau misfolding from the outside to the inside of a cell. J. Biol. Chem., 2009, 284, 12845-12852.
206. Speare, J. O., Offerdahl, D. K., Hasenkrug, A., Carmody, A. B. and Baron, G. S., GPI anchoring facilitates propagation and spread of misfolded Sup35 aggregates in mammalian cells. EMBO J., 2010, 29, 782-794.